help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Submit a related Letter to the Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Miura, Y.
Right arrow Articles by Magner, J. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Miura, Y.
Right arrow Articles by Magner, J. A.

Journal of Clinical Endocrinology & Metabolism, Vol 69, 985-995, Copyright © 1989 by Endocrine Society


ARTICLES

Concanavalin-A, lentil, and ricin lectin affinity binding characteristics of human thyrotropin: differences in the sialylation of thyrotropin in sera of euthyroid, primary, and central hypothyroid patients

Y Miura, VS Perkel, KA Papenberg, MJ Johnson and JA Magner
Division of Endocrinology, Michael Reese Hospital and Medical Center, University of Illinois, Chicago 60616.

TSH from human serum was separated into classes by serial lectin affinity chromatography using Concanavalin-A (ConA), lentil, and ricin lectins. TSH from 10 euthyroid subjects, 40 patients with primary hypothyroidism, and 1 patient with central hypothyroidism was studied. The patterns of ConA and lentil affinity binding were similar for diverse patients; forms of TSH that bound firmly to ConA also tended to bind firmly to lentil. Differences in TSH-ricin binding suggested that there were differences in the sialylation of TSH in sera of euthyroid, primary, and central hypothyroidism patients. For euthyroid subjects, 16.1 +/- 5.4% (mean +/- SD) of the TSH bound to ricin, while after neuraminidase treatment, 38.4 +/- 5.4% bound. For patients with primary hypothyroidism, 23.5 +/- 6.0% of the TSH bound to the ricin, while after neuraminidase treatment, 65.7 +/- 8.8% bound. The increase in ricin binding induced by neuraminidase treatment was significantly higher for TSH from patients with primary hypothyroidism than in that from euthyroid subjects (42.3 +/- 7.6% vs. 22.3 +/- 4.4%; P less than 0.01) and was greater for long term than for short term hypothyroid patients (49.5 +/- 5.0% vs. 36.5 +/- 6.5%; P less than 0.01). While 30% of native TSH from the serum of the patient with central hypothyroidism bound to ricin, the amount bound increased only 17.6% after neuraminidase treatment. McKenzie bioassay of pituitary-derived TSH that was similarly fractionated using ricin failed to show detectable differences in bioactivity among the lectin column fractions. Thus, 1) circulating human TSH can be consistently separated into discrete classes using serial lectin affinity chromatography; 2) there is relatively more core fucosylation of the less processed high mannose and hybrid forms of TSH and less core fucosylation of more processed complex forms; 3) ConA and lentil binding of TSH in primary and central hypothyroidism is similar to that in the euthyroid state; 4) patients with primary hypothyroidism have more sialylated TSH than a patient with central hypothyroidism or euthyroid subjects; and 5) the degree of TSH sialylation increases with prolonged primary hypothyroidism.


This article has been cited by other articles:


Home page
J. Clin. Endocrinol. Metab.Home page
J. H. A. Oliveira, E. R. Barbosa, T. Kasamatsu, and J. Abucham
Evidence for Thyroid Hormone as a Positive Regulator of Serum Thyrotropin Bioactivity
J. Clin. Endocrinol. Metab., August 1, 2007; 92(8): 3108 - 3113.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
S. Donadio, A. Pascual, J. H.H. Thijssen, and C. Ronin
Feasibility Study of New Calibrators for Thyroid-Stimulating Hormone (TSH) Immunoprocedures Based on Remodeling of Recombinant TSH to Mimic Glycoforms Circulating in Patients with Thyroid Disorders
Clin. Chem., February 1, 2006; 52(2): 286 - 297.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
R. Frenzel, K. Krohn, M. Eszlinger, A. Tonjes, and R. Paschke
Sialylation of Human Thyrotropin Receptor Improves and Prolongs Its Cell-Surface Expression
Mol. Pharmacol., October 1, 2005; 68(4): 1106 - 1113.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
J. H. A. Oliveira, L. Persani, P. Beck-Peccoz, and J. Abucham
Investigating the Paradox of Hypothyroidism and Increased Serum Thyrotropin (TSH) Levels in Sheehan's Syndrome: Characterization of TSH Carbohydrate Content and Bioactivity
J. Clin. Endocrinol. Metab., April 1, 2001; 86(4): 1694 - 1699.
[Abstract] [Full Text]


Home page
Endocr. Rev.Home page
M. Grossmann, B. D. Weintraub, and M. W. Szkudlinski
Novel Insights into the Molecular Mechanisms of Human Thyrotropin Action: Structural, Physiological, and Therapeutic Implications for the Glycoprotein Hormone Family
Endocr. Rev., August 1, 1997; 18(4): 476 - 501.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1989 by The Endocrine Society